Bjork Elisabeth 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Jun 16, 2021
Insider Transaction Report
Form 4
Bjork Elisabeth
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-14$29.42/sh+1,699$49,985→ 1,699 totalExercise: $47.25Exp: 2031-06-14→ Common Stock (1,699 underlying) - Award
Stock Option (Right to Buy)
2021-06-14+12,236→ 12,236 totalExercise: $47.25Exp: 2031-06-14→ Common Stock (12,236 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 12,236 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022.
- [F2]This option represents a right to purchase a total of 1,699 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000.